November 14, 2019
FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System
Editor's Note
The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious.
The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five complaints related to this issue, including one patient injury. No deaths have been reported.
Distribution dates for the system were April 8, 2016, to March 19, 2019.
Free Daily News
- US launches tariff investigations into medical supplies and devices, raising stakes for healthcare supply chain
- AORN: Periop patient ambassadors transform communication, outcomes in surgical care
- Government shutdown squeezes military medicine, halts NIH research, cuts CDC operations
- AI is transforming nursing practice but demands stronger ethics, training
- Government shutdown stalls healthcare access, freezes Medicare telehealth, hospital-at-home services
- ACS launches hospital search tool to spotlight surgical quality
- Higher MAP targets in acute spinal cord injury show no neurologic benefit, more complications
- Sports medicine procedures cost far less in ASCs than HOPDs
- Bariatric surgery outpaces GLP-1s in weight loss, cost savings
- Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement